Literature DB >> 12694655

Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.

Robert Kokenyesi1, Karuna P Murray, Abraham Benshushan, Edward D Huntley, Ming-Shian Kao.   

Abstract

OBJECTIVE: Primary peritoneal carcinosarcomas are similar to ovarian carcinomas in that they can metastasize by intraperitoneal dissemination; therefore, invasion of the submesothelial interstitial (stromal) matrix is an integral part of the pathology. Our objective was to study cell-matrix interactions that may influence invasive behavior of a novel, primary peritoneal carcinosarcoma cell line (PC880), and to assess how these cell-matrix interactions are different from frequently studied cultured ovarian carcinoma cells NIH:OVCAR-3, SKOV-3, and ES-2. We also wanted to determine how the expression of the cell-cell adhesion molecule E-cadherin is related to invasive behavior.
METHODS: The PC880 cell line was established from ascites fluid of a patient diagnosed with primary peritoneal carcinosarcoma. Adhesion assays were done in titer plates coated with individual matrix components. Cell migration in monolayer cultures was assessed by the scratch wound assay method. Invasion assays were done using a three-dimensional type I collagen gel. Cytokeratin, vimentin, and E-cadherin were detected by Western blotting. E-cadherin mRNA was detected by RT-PCR.
RESULTS: PC880 cells adhered well to fibronectin, laminin, and vitronectin in an integrin-dependent manner. The cells also adhered to type I collagen and invaded a three-dimensional type I collagen matrix. The invasiveness of the PC880 cells was moderated by pretreatment of the collagen matrix with heparin or chondroitin sulfate (82 and 63% of control invasiveness, respectively), indicating a role of cell surface proteoglycans in promoting invasive phenotype. Treatment of PC880 cells with sodium chlorate also decreased invasiveness (80% of control), further confirming the role of cell surface proteoglycans. Treatment of PC880 cells with function-blocking antibody to alpha2 integrin decreased invasiveness (57% of control), indicating the role of integrins in promoting the invasive phenotype. The protease inhibitors GM6001, E-64, and AEBSF decreased invasiveness (35, 57, and 37% of control, respectively) of PC880 cells. The ES-2 cells also adhered to type I collagen, and invaded the three-dimensional type I collagen matrix; however, inhibitors such as heparin, chondroitin sulfate, function-blocking antibody to alpha2 integrin, E-64, and AEBSF were less effective in moderating the invasiveness. Inhibition of invasiveness with sodium chlorate was the same as in PC880 cell, while GM6001 did not inhibit invasiveness at all. The NIH:OVCAR-3 and SK-OV-3 cells were previously found to adhere to type I collagen, but these cells did not invade the three-dimensional type I collagen matrix. In a monolayer culture PC880 and ES-2 cells had significantly higher motility than NIH:OVCAR-3 and SK-OV-3 cells. Only these noninvasive cell lines expressed E-cadherin protein or mRNA.
CONCLUSIONS: PC880 is the first cell line established from primary peritoneal carcinosarcoma, and the cytoskeletal composition indicated that these cells represent the sarcomatous elements of the tumor. PC880 cells, similar to ES-2 cells, adhered to type I collagen, and invaded a three-dimensional collagen matrix. The invasion of the interstitial matrix by both the peritoneal carcinosarcoma and the ovarian carcinoma cell line was mediated by cell surface proteoglycans, alpha2 integrin, and proteases. The invasive cell behavior of PC880 and ES-2 cells correlated with a high degree of motility, and with the lack of expression of the cell-cell adhesion molecule E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694655     DOI: 10.1016/s0090-8258(02)00152-x

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

Review 1.  Current treatment options for colon cancer peritoneal carcinomatosis.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  The interplay of cell-cell and cell-matrix interactions in the invasive properties of brain tumors.

Authors:  Balázs Hegedüs; Françoise Marga; Károly Jakab; Kathy L Sharpe-Timms; Gabor Forgacs
Journal:  Biophys J       Date:  2006-07-07       Impact factor: 4.033

3.  Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Tiffany Sin Hui Bong; Grace Hwei Ching Tan; Claramae Chia; Khee Chee Soo; Melissa Ching Ching Teo
Journal:  Int J Clin Oncol       Date:  2017-01-30       Impact factor: 3.402

4.  Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery.

Authors:  Simone Sibio; Cristina Fiorani; Carmine Stolfi; Andrea Divizia; Roberto Pezzuto; Fabrizio Montagnese; Giulia Bagaglini; Paolo Sammartino; Giuseppe Sigismondo Sica
Journal:  World J Gastrointest Surg       Date:  2015-09-27

5.  Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.

Authors:  Neveen Said; Kouros Motamed
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 6.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

7.  A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell-scaffold interaction and chemotherapeutic resistance of anticancer drugs.

Authors:  Zehong Yang; Xiaojun Zhao
Journal:  Int J Nanomedicine       Date:  2011-02-02

8.  Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone.

Authors:  N Zhu; R Lalla; P Eves; T L H Brown; A King; E H Kemp; J W Haycock; S MacNeil
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

9.  Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line.

Authors:  Yuh-Cheng Yang; Tsung-Chuan Ho; Show-Li Chen; Huei-Yi Lai; Ju-Yun Wu; Yeou-Ping Tsao
Journal:  BMC Cancer       Date:  2007-11-20       Impact factor: 4.430

10.  MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells.

Authors:  K L Sodek; M J Ringuette; T J Brown
Journal:  Br J Cancer       Date:  2007-07-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.